|
[Related PubMed/MEDLINE]
Total Number of Papers: 473
|
|
|
| |
|
[Display Entries]
|
|
>> all entries
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
Assessment of Malignancy Potential in Intraductal Papillary Mucinous Neoplasms of the Pancreas on MDCT. |
CI, HRS, ICG, NPV, OR, PPV, WFs |
| 2 |
2020 |
Comparison of imaging modalities for measuring the diameter of intraductal papillary mucinous neoplasms of the pancreas. |
CT, EUS, LOA, MRI |
| 3 |
2020 |
Diabetes and Weight Loss Are Associated With Malignancies in Patients With Intraductal Papillary Mucinous Neoplasms. |
OR |
| 4 |
2020 |
Endosonographic diagnosis of advanced neoplasia in intraductal papillary mucinous neoplasms. |
--- |
| 5 |
2020 |
EUS-guided confocal laser endomicroscopy: prediction of dysplasia in intraductal papillary mucinous neoplasms (with video). |
AUC, CI, HGD-Ca, IOA, LGD, nCLE |
| 6 |
2020 |
Evolution of the immune landscape during progression of pancreatic intraductal papillary mucinous neoplasms to invasive cancer. |
--- |
| 7 |
2020 |
Importance of each high-risk stigmata and worrisome features as a predictor of high-grade dysplasia in intraductal papillary mucinous neoplasms of the pancreas. |
HGD, HRS, LGD, OR |
| 8 |
2020 |
Invasive Intraductal Papillary Mucinous Neoplasms: CT Features of Colloid Carcinoma Versus Tubular Adenocarcinoma of the Pancreas. |
MPD |
| 9 |
2020 |
Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms. |
PDAC, SHRs |
| 10 |
2020 |
Methylated DNA in Pancreatic Juice Distinguishes Patients With Pancreatic Cancer From Controls. |
HGD, MDMs, PDACs |
| 11 |
2020 |
Multilocular Cyst of Type 1 Autoimmune Pancreatitis Masquerading as Cancerization of Intraductal Papillary Mucinous Neoplasm. |
AIP |
| 12 |
2020 |
Multimodal radiomics and cyst fluid inflammatory markers model to predict preoperative risk in intraductal papillary mucinous neoplasms. |
AUC, CFIM, CT, QI, TANs |
| 13 |
2020 |
Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy. |
CT, ICG |
| 14 |
2020 |
Mutational Mosaics of Cell-Free DNA from Pancreatic Cyst Fluids. |
cf, MCNs, PCFs, SCNs |
| 15 |
2020 |
Noninvasive Discrimination of Low and High-risk Pancreatic Intraductal Papillary Mucinous Neoplasms. |
--- |
| 16 |
2020 |
Prognosis of resected intraductal papillary mucinous neoplasm of the pancreas: using revised 2017 international consensus guidelines. |
CI, DSS, HR, RFS |
| 17 |
2020 |
Psychological distress in patients under surveillance for intraductal papillary mucinous neoplasms of the pancreas: The "Sword of Damocles" effect calls for an integrated medical and psychological approach a prospective analysis. |
Brief-COPE, BSMSS, PSS |
| 18 |
2020 |
Pylorus-Preserving Total Pancreatectomy for Intraductal Papillary Mucinous Neoplasm in the Setting of Previous Roux-en-Y Cystjejunostomy for Pancreatic Pseudocyst. |
--- |
| 19 |
2020 |
Serum Anti-p53 Antibody Can Serve as a Predictive Marker for Histological Grade of Intraductal Papillary Mucinous Neoplasms of the Pancreas. |
CA19-9, CEA, HGD, INV, S-p53Ab |
| 20 |
2020 |
Stratifying Intraductal Papillary Mucinous Neoplasms by Cyst Fluid Analysis: Present and Future. |
--- |
| 21 |
2020 |
Surgical strategy forintraductal papillary mucinous neoplasms ofthepancreas. |
HGD, IPMC |
| 22 |
2020 |
The Role of Positron Emission Tomography in Clinical Management of Intraductal Papillary Mucinous Neoplasms of the Pancreas. |
FDG, ICG, PET, PRISMA |
| 23 |
2019 |
A Consensus Study of the Grading and Typing of Intraductal Papillary Mucinous Neoplasms of the Pancreas. |
--- |
| 24 |
2019 |
Adjuvant chemotherapy is associated with improved postoperative survival in specific subtypes of invasive intraductal papillary mucinous neoplasms (IPMN) of the pancreas: it is time for randomized controlled data. |
DSS, IPMN |
| 25 |
2019 |
Age-related morphological changes in the pancreas and their association with pancreatic carcinogenesis. |
PanIN, PDAC |
| 26 |
2019 |
Benign Adrenocortical Tumors and the Detection of Nonadrenal Neoplasia. |
--- |
| 27 |
2019 |
Blood Type as a Predictor of High-Grade Dysplasia and Associated Malignancy in Patients with Intraductal Papillary Mucinous Neoplasms. |
--- |
| 28 |
2019 |
Characterization of Intraductal Papillary Neoplasm of the Bile Duct with Respect to the Histopathologic Similarities to Pancreatic Intraductal Papillary Mucinous Neoplasm. |
IPNBs |
| 29 |
2019 |
Cyst Fluid Biosignature to Predict Intraductal Papillary Mucinous Neoplasms of the Pancreas with High Malignant Potential. |
--- |
| 30 |
2019 |
Cyst location and presence of high grade dysplasia or invasive cancer in intraductal papillary mucinous neoplasms of the pancreas: a seven institution study from the central pancreas consortium. |
HGD, HRS, IC, WF |
| 31 |
2019 |
Cytologic Analysis of Pancreatic Juice Increases Specificity of Detection of Malignant IPMN-A Systematic Review. |
AUC |
| 32 |
2019 |
Determining Malignant Potential of Intraductal Papillary Mucinous Neoplasm of the Pancreas: CT versus MRI by Using Revised 2017 International Consensus Guidelines. |
IPMN |
| 33 |
2019 |
Development of a stratification tool to identify pancreatic intraductal papillary mucinous neoplasms at lowest risk of progression. |
--- |
| 34 |
2019 |
Endoscopic Ultrasound for Early Diagnosis of Pancreatic Cancer. |
CT, EUS, MRI |
| 35 |
2019 |
Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer. |
IL, PCN, PPI |
| 36 |
2019 |
GNAS but Not Extended RAS Mutations Spectrum are Associated with a Better Prognosis in Intraductal Pancreatic Mucinous Neoplasms. |
EGFR |
| 37 |
2019 |
Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated with the Stratified Risk of Cancer. |
BD, EUROPAC, FPC, IQR, PDAC |
| 38 |
2019 |
Increased Risk of Second Primary Cancers Following Diagnosis of Malignant Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Population-Based Study. |
CI, HRs, RR, SEER, SIR, SPCs |
| 39 |
2019 |
Increased SOX9 Expression in Premalignant and Malignant Pancreatic Neoplasms. |
BP, HG, LG |
| 40 |
2019 |
Integrated targeted metabolomic and lipidomic analysis: A novel approach to classifying early cystic precursors to invasive pancreatic cancer. |
HGD, LGD, PCNs, SCN |
| 41 |
2019 |
Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct Mutations. |
--- |
| 42 |
2019 |
Main duct and mixed type intraductal papillary mucinous neoplasms without enhancing mural nodules: Duct diameter of less than 10 mm and segmental dilatation of main pancreatic duct are findings support surveillance rather than immediate surgery. |
CI, HGD, MD, MNs, MPD, OR |
| 43 |
2019 |
Malignant conversion and peritoneal dissemination after endoscopic ultrasound-guided ethanol ablation in intraductal papillary mucinous neoplasm of the pancreas. |
EUS-PCA |
| 44 |
2019 |
Management and outcomes of intraductal papillary mucinous neoplasms. |
BD, DSS, MD, MT, PDAC |
| 45 |
2019 |
MRI Combined with Magnetic Resonance Cholangiopancreatography for Diagnosis of Benign and Malignant Pancreatic Intraductal Papillary Mucinous Neoplasms. |
MRCP, MRI |
| 46 |
2019 |
Neutrophil to Lymphocyte Ratio is a Predictive Factor of Malignant Potential for Intraductal Papillary Mucinous Neoplasms of the pancreas. |
HGD, IGD, LGD, NLR, PNI |
| 47 |
2019 |
Neutrophil-to-Lymphocyte Ratio as a Predictor of Invasive Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas. |
NLR |
| 48 |
2019 |
Obstructive cholangitis by mucus from an intraductal papillary mucinous neoplasm with pancreatobiliary fistula treated by endoscopic septotomy and direct peroral cholangioscopy: a case report. |
CT, ERCP |
| 49 |
2019 |
Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features. |
PDAs |
| 50 |
2019 |
Pitfalls of histopathological evaluation of EUS-guided microbiopsies from pancreatic cystic neoplasms. |
SCNs |
| 51 |
2019 |
Preoperative risk prediction for intraductal papillary mucinous neoplasms by quantitative CT image analysis. |
BD-IPMN |
| 52 |
2019 |
Prevalence of Asymptomatic Intraductal Papillary Mucinous Neoplasms in Healthy and Ill Populations Detected by Ultrasonography: A Single-Center Study of 6353 Outpatients. |
HRS, OR, WF |
| 53 |
2019 |
Prevalence of Germline Mutations Associated With Cancer Risk in Patients With Intraductal Papillary Mucinous Neoplasms. |
--- |
| 54 |
2019 |
Single-cell sequencing defines genetic heterogeneity in pancreatic cancer precursor lesions. |
--- |
| 55 |
2019 |
Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression. |
HGD-IPMN, LGD-IPMNs, PDAC |
| 56 |
2019 |
Subtyping of intraductal papillary mucinous neoplasms - pitfalls of MUC1 immunohistochemistry. |
PDAC |
| 57 |
2019 |
Subtyping of IPMN. |
--- |
| 58 |
2019 |
Talking Genes in Breast and Pancreatic Malignancies. |
FPC, PDAC |
| 59 |
2019 |
Testing for Verification Bias in Reported Malignancy Risks for Side-Branch Intraductal Papillary Mucinous Neoplasms: A Simulation Modeling Approach. |
PDAC |
| 60 |
2019 |
The Clinical Management of Main Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas. |
MPD |
| 61 |
2019 |
Usefulness of Deep Learning Analysis for the Diagnosis of Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas. |
AI, EUS |
| 62 |
2019 |
Validation of Indications for Surgery of European Evidence-Based Guidelines for Patients with Pancreatic Intraductal Papillary Mucinous Neoplasms. |
DM, EEBGPCN, HGD, IC |
| 63 |
2019 |
What is the Outcome of Patients Affected by Intraductal Papillary Mucinous Neoplasms Without High-Risk Stigmata?: A Single-Center Retrospective Study. |
HRS |
| 64 |
2018 |
A case of intraductal papillary-mucinous neoplasm of the pancreas penetrating into the stomach and spleen successfully treated by total pancreatectomy. |
CT, IPMC |
| 65 |
2018 |
A Functional Spatial Analysis Platform for Discovery of Immunological Interactions Predictive of Low-Grade to High-Grade Transition of Pancreatic Intraductal Papillary Mucinous Neoplasms. |
PDAC |
| 66 |
2018 |
Are pancreatic IPMN volumes measured on MRI images more reproducible than diameters? An assessment in a large single-institution cohort. |
ICCs, LOA |
| 67 |
2018 |
ARID1A Maintains Differentiation of Pancreatic Ductal Cells and Inhibits Development of Pancreatic Ductal Adenocarcinoma inMice. |
ATP, PanINs, PDACs, PDCs |
| 68 |
2018 |
Cells of origin of pancreatic neoplasms. |
MCNs, PanINs, PDAC |
| 69 |
2018 |
Clinical and Radiographic Gastrointestinal Abnormalities in McCune-Albright Syndrome. |
GI, MAS, MRCP |
| 70 |
2018 |
Conditional survival analysis for patients with intraductal papillary mucinous neoplasms (IPMNs) undergoing curative resection. |
CS, MD, PD, SEER, UD, WD |
| 71 |
2018 |
CT radiomics to predict high-risk intraductal papillary mucinous neoplasms of the pancreas. |
AUC, BD |
| 72 |
2018 |
Curative resection of pancreatic ductal adenocarcinoma developing in the remnant pancreas 13 years after distal pancreatectomy for intraductal papillary mucinous neoplasms: A case report. |
PDAC |
| 73 |
2018 |
Cyst Fluid Biomarkers - Diagnosis and Prediction of Malignancy for Cystic Lesions of the Pancreas. |
MCNs |
| 74 |
2018 |
Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium. |
BD |
| 75 |
2018 |
Does Surgical Margin Impact Recurrence in Noninvasive Intraductal Papillary Mucinous Neoplasms?: A Multi-institutional Study. |
--- |
| 76 |
2018 |
Evaluation of the International Consensus Guidelines for the Surgical Resection of Intraductal Papillary Mucinous Neoplasms. |
MPD |
| 77 |
2018 |
GNASR201C Induces Pancreatic Cystic Neoplasms in Mice That Express Activated KRAS by Inhibiting YAP1 Signaling. |
PDACs, YAP |
| 78 |
2018 |
Identification of a pyruvate-to-lactate signature in pancreatic intraductal papillary mucinous neoplasms. |
HGD, IHC, LGD |
| 79 |
2018 |
Imaging Follow-up of Low-Risk Incidental Pancreas and Kidney Findings: Effects of Patient Age and Comorbidity on Projected Life Expectancy. |
LE, SB |
| 80 |
2018 |
Improved Detection of Circulating Epithelial Cells in Patients with Intraductal Papillary Mucinous Neoplasms. |
CECs |
| 81 |
2018 |
Intraductal Papillary Mucinous Neoplasm of the Pancreas in Young Patients: Tumor Biology, Clinical Features, and Survival Outcomes. |
--- |
| 82 |
2018 |
Intraductal papillary mucinous neoplasms of the pancreas: a clinical challenge. |
--- |
| 83 |
2018 |
Intraductal Papillary Mucinous Neoplasms of the Pancreas: Current Understanding and Future Directions for Stratification of Malignancy Risk. |
--- |
| 84 |
2018 |
IPMNs with co-occurring invasive cancers: neighbours but not always relatives. |
--- |
| 85 |
2018 |
Loss of Pten and Activation of Kras Synergistically Induce Formation of Intraductal Papillary Mucinous Neoplasia From Pancreatic Ductal Cells in Mice. |
PDACs |
| 86 |
2018 |
Mass Spectrometry-Based Comprehensive Analysis of Pancreatic Cyst Fluids. |
CAs, MCNs, PCFs, PCLs, PCs, SCNs |
| 87 |
2018 |
Meta-analysis of mortality in patients with high-risk intraductal papillary mucinous neoplasms under observation. |
--- |
| 88 |
2018 |
Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism. |
GNAS, PDAs |
| 89 |
2018 |
Pancreatic Cancer Cell Fraction Estimation in a DNA Sample. |
--- |
| 90 |
2018 |
Pancreatic Fat Content Detected by Computed Tomography and Its Significant Relationship With Intraductal Papillary Mucinous Neoplasm. |
PDACs |
| 91 |
2018 |
Pancreatobiliary fistula associated with intraductal papillary mucinous carcinoma accompanying obstructive jaundice: A case report. |
--- |
| 92 |
2018 |
Precursor Lesions of Pancreatic Cancer. |
IOPNs, ITPNs, MCNs, PanINs, PDAC |
| 93 |
2018 |
Predictors of Progression Among Low-Risk Intraductal Papillary Mucinous Neoplasms in a Multicenter Surveillance Cohort. |
--- |
| 94 |
2018 |
Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia. |
EUS, MCNs, NGS, PCF, PCs |
| 95 |
2018 |
Prevalence of Extrapancreatic Malignancies Among Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas. |
CI, EPMs |
| 96 |
2018 |
Quantitative proteomic analysis of pancreatic cyst fluid proteins associated with malignancy in intraductal papillary mucinous neoplasms. |
HGD, LGD |
| 97 |
2018 |
Significance of microcystic, elongated, and fragmented glandular-like features in intraductal papillary mucinous neoplasm of the pancreas. |
MELF |
| 98 |
2018 |
Simple Detection of Telomere Fusions in Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasm, and Pancreatic Cyst Fluid. |
HGD |
| 99 |
2018 |
Surgical Treatment of a Mucinous Cystic Neoplasm in a Young Female Patient - A Case Report. |
MCNs, SCTs, SPNs |
| 100 |
2018 |
The role of age in pancreatic intraductal papillary mucinous neoplasms of the pancreas: Same risk of death but different implications for management. |
DSS, HRS, OS |
|
A Search Service for Abbreviation / Long Form
